Skip NavigationSkip to Primary Content

DVM, MS, DACVIM (Neurology)

Aaron J. Rozental

Aaron J. Rozental

DVM, MS, DACVIM (Neurology)

Aaron J. Rozental

Veterinary School: Ross University, St. Kitts & Nevis 

Internship Training: BluePearl Pet Hospital (Northfield and Skokie, IL) 

Neurology Internship Training: Veterinary Specialty Center of Seattle, Seattle, WA (Small Animal Neurology) 

Neurology Research Internship: Colorado State University, Fort Collins, CO 

Residency Training: Colorado State University, Fort Collins, CO 

Certification: Diplomate ACVIM (Neurology) (2023); 

Masters of Science: Colorado State University, Fort Collins, CO (2023)

Dr. Aaron Rozental began his veterinary career at Michigan State University where he earned his Bachelor’s of Science degree in zoology. He attended veterinary school at Ross University in St. Kitts, and completed his clinical year at the University of Missouri. Dr. Rozental then moved back home to Chicago to complete a general rotating internship before moving to Seattle for a neurology specialty internship. Dr. Rozental was invited to Colorado State University where he spent a year as a research intern. He was then invited to join the veterinary neurology department at Colorado State University for a three year residency program. 

During the residency, Dr. Rozental also completed a Masters of Science degree, which was based on his research efforts focusing on the veterinary use of CBD. He has presented CBD research at multiple veterinary symposia and grand rounds and has been published on this topic and others. His biggest research interests lie in CBD and the endocannabinoid system.

Dr. Rozental particularly enjoys the reward of making dogs previously unable to walk - walk again after surgery and is passionate about treating epilepsy and infectious diseases. 

Outside of work, Aaron enjoys hiking, traveling, gardening, and cooking

Published works:

Rozental AJ, Weisbeck BT, Corsato Alvarenga I, Gustafson DL, Kusick BR, Rao S, Bartner LR, McGrath S. The efficacy and safety of cannabidiol as adjunct therapy for drug-resistant idiopathic epilepsy in 51 dogs: A double-blinded crossover study. J Vet Intern Med. (2023).

Ammons DT, Guth A, Rozental AJ, Kurihara J, Marolf AJ, Chow L, Griffin JF 4th, Makii R, MacQuiddy B, Boss MK, Regan DP, Frank C, McGrath S, Packer RA, Dow S. Reprogramming the Canine Glioma Microenvironment with Tumor Vaccination plus Oral Losartan and Propranolol Induces Objective Responses. Cancer Res Commun. 2022 Dec;2(12):1657-1667.

Rozental AJ, Gustafson DL, Kusick BR, Bartner LR, Castro SC, McGrath S. Pharmacokinetics of escalating single-dose administration of cannabidiol to cats. J Vet Pharmacol Ther. 2023 Jan;46(1):25-33.

Rozental AJ, McGrath S, Mooney AP, Hinson SR, McKeon A, Pittock SJ, Gross CC, Tyler KL. Evaluation of cell-based and tissue-based immunofluorescent assays for detection of glial fibrillary acidic protein autoantibodies in the cerebrospinal fluid of dogs with meningoencephalitis of unknown origin and other central nervous system disorders. Am J Vet Res. 2021 Feb;82(2):132-137.

Rozental AJ, Partnow AB, Shomper JL, Schultz RM. What Is Your Neurologic Diagnosis? J Am Vet Med Assoc. 2020 Apr 1;256(7):771-774.

https://cvmbs.source.colostate.edu/a-tangled-web-teasing-out-the-effects-of-cbd-on-canine-seizures/